Companies
Gilead Sciences Inc. (NASDAQ:GILD): The Fundamentals Have Changed
Gilead Sciences Inc. (NASDAQ:GILD) previous close was $68.77 while the outstanding shares total 1.26B. The firm has a beta of 0.39, a 12-month trailing P/E
Gilead Sciences Inc. (NASDAQ:GILD) previous close was $68.77 while the outstanding shares total 1.26B. The firm has a beta of 0.39, a 12-month trailing P/E
Gilead Sciences Inc. (NASDAQ:GILD) has a beta of 0.39, a 12-month trailing P/E ratio of 327.28, and a growth ratio of 110.01. The stock’s Relative
Gilead Sciences Inc. (NASDAQ:GILD) previous close was $66.11 while the outstanding shares total 1.26B. The firm has a beta of 0.40, a 12-month trailing P/E
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne